Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. clearpemplus

ClearPEMplus

Enhanced Silicon Photomultiplier-based detectors for high-resolution Positron Emission Mammography.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 ClearPEMplus project word cloud

Explore the words cloud of the ClearPEMplus project. It provides you a very rough idea of what is the project "ClearPEMplus" about.

photodetector    situations    young    scarce    enhanced    detecting    technique    circuits    industrialization    device    additional    strategy    detection    complement    supply    women    larger    1    beneficial    removal    clinics    hospitals    resolution    implants    history    scanners    light    module    rate    plan    dense    implies    tomography    solid    complete    single    cancer    silicon    market    body    establishing    sound    designed    elaboration    distress    operation    electronics    exact    marketing    emission    outcome    signal    critical    innovative    housing    mammography    cure    read    extreme    clearpem    petsys    replying    departments    sensitivity    screening    scanner    exams    commercialization    positive    positron    breast    model    tailoring    detector    imaging    performing    lesions    chain    clinical    hospital    trials    unnecessary    million    fold    survival    spatial    mm    specificity    5cm    business    localization    healthcare    tumours    suffer    effect    small    pet    staging    false    battle    planning    tumor    sipm    asics   

Project "ClearPEMplus" data sheet

The following table provides information about the project.

Coordinator		 PETSYS ELECTRONICS - MEDICAL PET DETECTORS SA 

Organization address
address: TAGUSPARK EDIFICIO TECNOLOGIA I 26
city: PORTO SALVO
postcode: 2740 122
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Portugal [PT]
 Project website http://www.petsyselectronics.pt
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2016-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PETSYS ELECTRONICS - MEDICAL PET DETECTORS SA PT (PORTO SALVO) coordinator 50˙000.00

Map

 Project objective

Breast cancer affects more than 1.7 million women each year in Europe. Early detection and exact staging (single or multi-localization) is of extreme importance for improving the survival rate and cure outcome, and tailoring the operation (tumor or whole-breast removal). Currently mammography is the technique of choice for breast cancer screening, with positive cases addressed to further exams. Positron Emission Tomography (PET) imaging is beneficial to complement mammography in many situations: screening of critical cases with cancer history, detection in young women with dense breast or silicon implants, and to evaluate the effect of a cure. However whole-body PET scanners suffer of scarce sensitivity and are effective only in detecting tumours larger than 1-1.5cm. PETsys Electronics has designed and developed an innovative detector module for PET scanner based on the SiPM photodetector, a solid state device with enhanced sensitivity to low–light signal, that is read out by their novel highly integrated Application Specific Integrated Circuits (ASICs). The housing is specifically designed for breast cancer detection. Currently, ClearPEM is the only PET breast scanner based on the SiPM photodetector, which allows to provide a 10-fold larger sensitivity than whole body PET scanner. The improved spatial resolution enables to identify breast lesions as small as 1-2 mm. ClearPEM addresses the market of hospitals and clinics replying to their need of enhancing the specificity of mammography screening in breast cancer detection to battle the increasing rate of false-positive results, which implies additional cost for the healthcare system and unnecessary distress for women. The Phase 1 project will be focused on establishing a complete supply chain, a sound business model and commercialization strategy, a planning of all activities for performing the clinical trials in hospital departments, as well as the elaboration of an industrialization and marketing plan.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLEARPEMPLUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLEARPEMPLUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

INADVANCE (2019)

Patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard

Read More